High-dose naloxone in tardive dyskinesia

Jean Pierre Lindenmayer, Eliot Gardner, Elkhonon Goldberg, Lewis A. Opler, Stanley R. Kay, Herman M. van Praag, Michelle Weiner, R. Suzanne Zukin

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Tardive dyskinesia (TD) is thought to result from nigrostriatal dopaminergic supersensitivity secondary to prolonged neuroleptic exposure. Preclinical studies have demonstrated that the opiate antagonist naloxone can acutely reverse a haloperidol-induced hyperdopaminergic state. In a trial of high-dose naloxone, 20 patients with TD received i.v. naloxone (20 mg, 40 mg, and placebo) under double-blind conditions. At baseline and at regular postdrug intervals, patients were evaluated using a battery of motor, clinical, and neuropsychological measures to study effects on neurological, behavioral, and cognitive functions. There was a significant improvement in involuntary movements at 30 min postnaloxone, together with improvement in clinical ratings at that time point, as well as some cognitive changes. The implications of these findings for the putative functional relationship between dopaminergic and enkephalinergic systems in the nigrostriatal area are discussed.

Original languageEnglish (US)
Pages (from-to)19-28
Number of pages10
JournalPsychiatry Research
Volume26
Issue number1
DOIs
StatePublished - 1988

Fingerprint

Naloxone
Opiate Alkaloids
Dyskinesias
Haloperidol
Cognition
Antipsychotic Agents
Placebos
Tardive Dyskinesia

Keywords

  • involuntary movements
  • naloxone
  • psychiatric symptoms
  • Tardive dyskinesia

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry
  • Psychology(all)

Cite this

Lindenmayer, J. P., Gardner, E., Goldberg, E., Opler, L. A., Kay, S. R., van Praag, H. M., ... Zukin, R. S. (1988). High-dose naloxone in tardive dyskinesia. Psychiatry Research, 26(1), 19-28. https://doi.org/10.1016/0165-1781(88)90083-2

High-dose naloxone in tardive dyskinesia. / Lindenmayer, Jean Pierre; Gardner, Eliot; Goldberg, Elkhonon; Opler, Lewis A.; Kay, Stanley R.; van Praag, Herman M.; Weiner, Michelle; Zukin, R. Suzanne.

In: Psychiatry Research, Vol. 26, No. 1, 1988, p. 19-28.

Research output: Contribution to journalArticle

Lindenmayer, JP, Gardner, E, Goldberg, E, Opler, LA, Kay, SR, van Praag, HM, Weiner, M & Zukin, RS 1988, 'High-dose naloxone in tardive dyskinesia', Psychiatry Research, vol. 26, no. 1, pp. 19-28. https://doi.org/10.1016/0165-1781(88)90083-2
Lindenmayer JP, Gardner E, Goldberg E, Opler LA, Kay SR, van Praag HM et al. High-dose naloxone in tardive dyskinesia. Psychiatry Research. 1988;26(1):19-28. https://doi.org/10.1016/0165-1781(88)90083-2
Lindenmayer, Jean Pierre ; Gardner, Eliot ; Goldberg, Elkhonon ; Opler, Lewis A. ; Kay, Stanley R. ; van Praag, Herman M. ; Weiner, Michelle ; Zukin, R. Suzanne. / High-dose naloxone in tardive dyskinesia. In: Psychiatry Research. 1988 ; Vol. 26, No. 1. pp. 19-28.
@article{01615a2fb0404f079a6b999d9844597f,
title = "High-dose naloxone in tardive dyskinesia",
abstract = "Tardive dyskinesia (TD) is thought to result from nigrostriatal dopaminergic supersensitivity secondary to prolonged neuroleptic exposure. Preclinical studies have demonstrated that the opiate antagonist naloxone can acutely reverse a haloperidol-induced hyperdopaminergic state. In a trial of high-dose naloxone, 20 patients with TD received i.v. naloxone (20 mg, 40 mg, and placebo) under double-blind conditions. At baseline and at regular postdrug intervals, patients were evaluated using a battery of motor, clinical, and neuropsychological measures to study effects on neurological, behavioral, and cognitive functions. There was a significant improvement in involuntary movements at 30 min postnaloxone, together with improvement in clinical ratings at that time point, as well as some cognitive changes. The implications of these findings for the putative functional relationship between dopaminergic and enkephalinergic systems in the nigrostriatal area are discussed.",
keywords = "involuntary movements, naloxone, psychiatric symptoms, Tardive dyskinesia",
author = "Lindenmayer, {Jean Pierre} and Eliot Gardner and Elkhonon Goldberg and Opler, {Lewis A.} and Kay, {Stanley R.} and {van Praag}, {Herman M.} and Michelle Weiner and Zukin, {R. Suzanne}",
year = "1988",
doi = "10.1016/0165-1781(88)90083-2",
language = "English (US)",
volume = "26",
pages = "19--28",
journal = "Psychiatry Research",
issn = "0165-1781",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - High-dose naloxone in tardive dyskinesia

AU - Lindenmayer, Jean Pierre

AU - Gardner, Eliot

AU - Goldberg, Elkhonon

AU - Opler, Lewis A.

AU - Kay, Stanley R.

AU - van Praag, Herman M.

AU - Weiner, Michelle

AU - Zukin, R. Suzanne

PY - 1988

Y1 - 1988

N2 - Tardive dyskinesia (TD) is thought to result from nigrostriatal dopaminergic supersensitivity secondary to prolonged neuroleptic exposure. Preclinical studies have demonstrated that the opiate antagonist naloxone can acutely reverse a haloperidol-induced hyperdopaminergic state. In a trial of high-dose naloxone, 20 patients with TD received i.v. naloxone (20 mg, 40 mg, and placebo) under double-blind conditions. At baseline and at regular postdrug intervals, patients were evaluated using a battery of motor, clinical, and neuropsychological measures to study effects on neurological, behavioral, and cognitive functions. There was a significant improvement in involuntary movements at 30 min postnaloxone, together with improvement in clinical ratings at that time point, as well as some cognitive changes. The implications of these findings for the putative functional relationship between dopaminergic and enkephalinergic systems in the nigrostriatal area are discussed.

AB - Tardive dyskinesia (TD) is thought to result from nigrostriatal dopaminergic supersensitivity secondary to prolonged neuroleptic exposure. Preclinical studies have demonstrated that the opiate antagonist naloxone can acutely reverse a haloperidol-induced hyperdopaminergic state. In a trial of high-dose naloxone, 20 patients with TD received i.v. naloxone (20 mg, 40 mg, and placebo) under double-blind conditions. At baseline and at regular postdrug intervals, patients were evaluated using a battery of motor, clinical, and neuropsychological measures to study effects on neurological, behavioral, and cognitive functions. There was a significant improvement in involuntary movements at 30 min postnaloxone, together with improvement in clinical ratings at that time point, as well as some cognitive changes. The implications of these findings for the putative functional relationship between dopaminergic and enkephalinergic systems in the nigrostriatal area are discussed.

KW - involuntary movements

KW - naloxone

KW - psychiatric symptoms

KW - Tardive dyskinesia

UR - http://www.scopus.com/inward/record.url?scp=0023752382&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023752382&partnerID=8YFLogxK

U2 - 10.1016/0165-1781(88)90083-2

DO - 10.1016/0165-1781(88)90083-2

M3 - Article

VL - 26

SP - 19

EP - 28

JO - Psychiatry Research

JF - Psychiatry Research

SN - 0165-1781

IS - 1

ER -